Literature DB >> 8002736

[Prevalence and clinical aspects of A and B subgroups of respiratory syncytial virus infection. Observation of 8 consecutive epidemics between 1982 and 1990].

J Brouard1, F Freymuth, S Constantini, J Petitjean, G de Schrevel, J F Duhamel.   

Abstract

BACKGROUND: Infants suffering from respiratory syncytial virus (RSV) infection can have severe responses that require intensive care. This study compares the epidemiologic patterns and the severity of respiratory diseases produced by RSV strain subtypes A and B. POPULATION AND METHODS: The prevalence of RSV subgroups was studied over 8 consecutive outbreaks from 1982 to 1990. The files of 73 infants aged from 1 to 24 months admitted because of RSV infection between October 1987 and March 1990 were studied. The criteria of severity were tachypnea and/or the use of the accessory muscles for respiration, apnea and/or cyanosis, hospitalization for > 8 days, hypercapnia and/or acidosis, oxygen therapy, use of corticosteroids and/or bronchodilators, nutritional difficulties.
RESULTS: A total of 374 RSV strains were isolated: 142 were group A and were 232 group B. Subtype A predominated during the winter 1987-1988 and subtype B during 1983-1984, 1984-1985 and 1989-1990. Some indicators of severity, such as degree of respiratory distress, duration of hospitalization and levels of oxygen saturation, were correlated with A subgroup infections, but the difference in the severity index for the two subtypes was not statistically significant.
CONCLUSIONS: The results are not consistent with other previous reports, perhaps because different indicators of severity were used in this study and infants less than one month old or having other underlying diseases were excluded.

Entities:  

Mesh:

Year:  1993        PMID: 8002736

Source DB:  PubMed          Journal:  Arch Fr Pediatr        ISSN: 0003-9764


  7 in total

1.  Respiratory Syncytial Virus Genotypes, Host Immune Profiles, and Disease Severity in Young Children Hospitalized With Bronchiolitis.

Authors:  Rosa Rodriguez-Fernandez; Lorena I Tapia; Chin-Fen Yang; Juan Pablo Torres; Susana Chavez-Bueno; Carla Garcia; Lisa M Jaramillo; Melissa Moore-Clingenpeel; Hasan S Jafri; Mark E Peeples; Pedro A Piedra; Octavio Ramilo; Asuncion Mejias
Journal:  J Infect Dis       Date:  2017-12-27       Impact factor: 5.226

2.  Comparison of a real-time reverse transcriptase PCR assay and a culture technique for quantitative assessment of viral load in children naturally infected with respiratory syncytial virus.

Authors:  Stephanie M Perkins; David L Webb; Shauna A Torrance; Chadi El Saleeby; Lisa M Harrison; Jody A Aitken; Anami Patel; John P DeVincenzo
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

Review 3.  Human genetic factors and respiratory syncytial virus disease severity.

Authors:  Isao Miyairi; John P DeVincenzo
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

4.  A Virological and Phylogenetic Analysis of the Emergence of New Clades of Respiratory Syncytial Virus.

Authors:  Farah Elawar; Cameron D Griffiths; Daniel Zhu; Leanne M Bilawchuk; Lionel D Jensen; Lydia Forss; Julian Tang; Bart Hazes; Steven J Drews; David J Marchant
Journal:  Sci Rep       Date:  2017-09-25       Impact factor: 4.379

5.  [Bronchiolitis viruses].

Authors:  F Freymuth; A Vabret; J Dina; D Cuvillon-Nimal; C Lubin; A Vaudecrane; B Guillois; S Gouarin; J Petitjean; F Lafaix-Delaire; J Brouard
Journal:  Arch Pediatr       Date:  2010-06-16       Impact factor: 1.180

6. 

Authors:  F Freymuth
Journal:  EMC Pediatr       Date:  2011-08-10

7.  Human respiratory syncytial virus (hRSV) RNA quantification in nasopharyngeal secretions identifies the hRSV etiologic role in acute respiratory tract infections of hospitalized infants.

Authors:  Giulia Campanini; Elena Percivalle; Fausto Baldanti; Francesca Rovida; Alice Bertaina; Antonietta Marchi; Mauro Stronati; Giuseppe Gerna
Journal:  J Clin Virol       Date:  2007-04-23       Impact factor: 3.168

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.